Related Experiment Video

Updated: Jun 17, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review

T Vainas1, S Sayed, C A Bruggeman

  • 1Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.

Drugs of Today (Barcelona, Spain : 1998)
|December 17, 2009
PubMed

Insights

Chlamydia pneumoniae infections are linked to atherosclerosis development, with evidence found in vascular tissue. However, antibiotics are not recommended for preventing cardiovascular events related to this infection.

Area of Science:

  • Infectious Disease
  • Cardiovascular Science
  • Pathology

Background:

  • Chlamydia pneumoniae infections are increasingly implicated in atherosclerosis.
  • Serological and pathological studies suggest a link between C. pneumoniae and atherosclerotic disease.
  • Both vascular and systemic effects of C. pneumoniae infection may contribute to atherosclerosis.

Purpose of the Study:

  • To review the evidence for Chlamydia pneumoniae's role in cardiovascular disease development.
  • To evaluate potential mechanisms linking C. pneumoniae infection to atherosclerosis.
  • To assess the clinical implications of C. pneumoniae in cardiovascular pathology.

Main Methods:

  • Narrative review of existing scientific literature.
  • Analysis of seroepidemiological, pathological, and experimental studies.
  • Evaluation of proposed molecular and systemic mechanisms.

Main Results:

  • Multiple studies suggest a correlation between C. pneumoniae infection and atherosclerosis.
  • C. pneumoniae is frequently detected in atherosclerotic vascular tissue.
  • Experimental data supports mechanisms for C. pneumoniae-induced atherogenesis.
  • Antibiotic therapy shows no benefit in secondary prevention of related cardiovascular events.

Conclusions:

  • Chlamydia pneumoniae infection is a significant factor in atherosclerosis development.
  • Further research is needed to fully elucidate the role of C. pneumoniae in cardiovascular disease.
  • Current evidence does not support antibiotic use for secondary prevention in this context.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...